Currently Viewing:
ISPOR 2018
Dr Harlan Krumholz Outlines the Impact of New Technology and Innovations on Healthcare Delivery
May 21, 2018
Value Assessments Are Just One Tool in the Decision-Maker's Toolkit, Panel Says
May 21, 2018
Transforming Healthcare: Boosting Real-World Evidence With Digital Health
May 21, 2018
Sally Okun: It's Time to Empower the Health Data Being Collected
May 21, 2018
Dr Clifford Goodman Discusses the Challenge of Valuing New, Expensive Therapies for Rare Diseases
May 22, 2018
All-Cause Healthcare Payments Substantial for Younger Adults With Depression, and Other Poster Findings at ISPOR
May 22, 2018
Personalizing the Digital Data Revolution in Healthcare
May 22, 2018
Dr Adrian Hernandez Highlights the Use of Real-World Evidence and Current Barriers
May 22, 2018
Panelists Give Payer, Patient, and Economist Perspectives on High-Cost Drugs for Rare Diseases
May 23, 2018
Dr Steven Pearson Highlights the Challenge of Evaluating New Interventions That Cure Diseases
May 23, 2018
Dr Ejim Mark: Digital Health Runs the Risk of Exacerbating Disparities
May 23, 2018
Value Assessments in the Age of Personalized Medicine May Require a Cultural Shift, Panel Says
May 23, 2018
Valuation Challenges and Ethical Implications of Cures
May 23, 2018
Sally Okun: Using Digital Health Improvements to Include the Patient Voice in Healthcare
June 14, 2018
Dr Harlan Krumholz on Using New Technologies, Data Generation to Prevent or Address Epidemics
June 18, 2018
Dr Adrian F. Hernandez on the Future of Real-World Evidence
June 20, 2018
Currently Reading
Sally Okun Outlines What Patients Define as Good Care
June 26, 2018
Dr Harlan Krumholz: How Healthcare Can Better Implement New Technologies
June 29, 2018
Dr Adrian F. Hernandez: Mapping Human Health Through Project Baseline
July 03, 2018
Sally Okun on How Informed Patients Feel When Starting Treatment After a New Diagnosis
July 09, 2018
Dr Clifford Goodman on Progress With the Move to Value-Based Payments
July 09, 2018
Dr Clifford Goodman Discusses How Healthcare Should Address Social Determinants of Health
July 20, 2018
Dr Harlan Krumholz on Barriers Preventing Healthcare From Using Data to Improve Care
August 01, 2018

Sally Okun Outlines What Patients Define as Good Care

Sally Okun, RN, MMHS, vice president, Policy and Ethics, PatientsLikeMe, discusses findings from PatientsLikeMe's research on what patients define as good care.


This page contains sponsored advertising.

Sally Okun, RN, MMHS, vice president, Policy and Ethics, PatientsLikeMe, discusses findings from PatientsLikeMe's research on what patients define as good care.

Transcript 

PatientsLikeMe recently performed some research on what patients define as “good care.” What were some of the key findings?

There’s 10 themes that we actually distilled down from 1200 different themes that were actually provided by a variety of people: patients as well as members of our PatientLikeMe site. Then, people actually from a clinic here in Baltimore participated in it, as well, because we really wanted to get a diverse understanding of how might a person define what good care looks like to them. I think the 3 key themes that stood out to me was first, “let me know how I can be an active participant in my care.” That, I think, is reflecting where we are today from where we were a generation ago, where most people just allow their clinicians or their doctors to tell them what they needed to do and then they moved ahead with their health. Today, consumers and patients, whether you consider yourself a consumer or patient, really are expecting more of a partner role, and I think that the healthcare system hasn’t quite caught up yet. They are sort of a little bit behind, so I think that was 1 of the very first things that stood out for me, and that highlighted an opportunity that we have; its beyond engagement, it’s a partnership, and we must really begin thinking about that.

The other key theme was to focus on outcomes. Patients really wanted to know, “What will happen as a result of the treatment that you’re thinking about giving me? What has happened with other people that you’ve given this treatment to in the past?” They want to see more information about if that actually translates into something that is more realistic for them. Statistical averages and things like that, for most patients, is hard to digest, so when I think they could put it in some perspective that’s more about them, they understand what their role is, and they have a better understanding of what they might measure in terms of seeing how well the outcome went. Then, it actually really starts to create this full range of spectrum of partnerships along the way.

Lastly, I’d say the piece around collaboration, understanding that, “I am more than just a disease, or I am more than just the condition that you’ve diagnosed me with, that I’m a whole person,” and so understanding how that comes together when you see me at the point of care in my doctor’s visit is really an important consideration for patients. We estimate that 99% of the time we are not with our doctors. So, for that amount of time, we need to be always making our own decisions and trying to figure out what our best path will be forward. When we have that 1% of our time with our clinicians, it’s probably going to be best used brining in that information that people have from their personal experiences living with health conditions over time, and we’ve not previously harnessed that information in an effective way, and I think now we’re seeing patients and consumers want us to do that.

 
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up